chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I had a mild case of covid; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (I had a mild case of covid) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form and second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced COVID-19 (I had a mild case of covid). The patient was treated with NIRMATRELVIR, RITONAVIR (PAXLOVID) from 02-May-2022 to 06-May-2022 for COVID-19 treatment, at an unspecified dose and frequency. At the time of the report, COVID-19 (I had a mild case of covid) outcome was unknown.            Concomitant and treatment medication were not reported.  Company comment-This spontaneous case concerns a female patient of unknown age, with no medical history reported, who experienced the non-serious unexpected AESI of COVID-19(reported as I had a mild case of covid) on an unknown date after third dose of mRNA-1273 vaccine. Patient reported Covid-19 on an unknown date and was treated with PAXLOVID((NIRMATRELVIR, RITONAVIR) for 5 days (from 2nd May to 6th May 2022). No further details on clinical course, lab test results were reported. Patient had received initial two doses of vaccine with Moderna on unknown dates. Outcome of the event was not known at the time of report. The current pandemic situation of COVID 19 may remain as confounder to the event Covid-19.  The benefit-risk relationship of mRNA-1273 Vaccine is not affected by this report.; Sender's Comments: This spontaneous case concerns a female patient of unknown age, with no medical history reported, who experienced the non-serious unexpected AESI of COVID-19(reported as I had a mild case of covid) on an unknown date after third dose of mRNA-1273 vaccine. Patient reported Covid-19 on an unknown date and was treated with PAXLOVID((NIRMATRELVIR, RITONAVIR) for 5 days (from 2nd May to 6th May 2022). No further details on clinical course, lab test results were reported. Patient had received initial two doses of vaccine with Moderna on unknown dates. Outcome of the event was not known at the time of report. The current pandemic situation of COVID 19 may remain as confounder to the event Covid-19.  The benefit-risk relationship of mRNA-1273 Vaccine is not affected by this report.
15 minutes after getting vaccinated patient stated that her tongue felt itchy. I ask if she felt anything else , she said it's itchy and she may felt a little swollen tongue. I  ask patient to wait another 15 minutes and let me know if she needed emergency service. In about ten minutes she told one of our tech she would like emergency service. I call 911 and was referred to paramedic line. They told me to watch patient and have Epipen ready. When ems arrive she said her daughter also felt itchy tongue. I let EMS take care of patient. After close at 7 pm. I made a call to follow up and patient said she was ok
Left lower eyelid involuntary twitching; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 44 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 2021 (Lot number: FF2587) as dose 2, single for covid-19 immunisation. Relevant medical history included: "Seasonal Bronchitis" (unspecified if ongoing); "known allergies Penicillin" (unspecified if ongoing); "covid" (unspecified if ongoing), notes: If covid prior vaccination: Yes. There were no concomitant medications. Vaccination history included: Bnt162b2 (Dose number: 01, lot number: FD0809, administration time: 12:45 PM, vaccine location: Left arm), administration date: 25Aug2021, when the patient was 44 years old, for COVID-19 immunization, reaction(s): "Chest pain", "Left lower eyelid involuntary twitching". The following information was reported: BLEPHAROSPASM (non-serious) with onset 29Aug2021 12:00, outcome "recovering", described as "Left lower eyelid involuntary twitching". Therapeutic measures were not taken as a result of blepharospasm.  Additional information: No other vaccine in four weeks. No other medications in two weeks. Patient experienced chest pain for 5 days, 4 days after the first dose of Pfizer Covid 19 vaccine. Left lower eyelid involuntary twitching, 4 days after first dose of Pfizer COVID-19 vaccine, which up to the second dose still persist. Patient had covid prior vaccination. Patient was not tested for covid post vaccination.  Follow-up attempts are completed. No further information is expected.
For approximately 5 days after I received the first shot of the Pfizer vaccine I had muscle pain up and down both arms and both legs.  It hurt to sit, stand, and walk.  Certain areas on my arms and legs were sensitive to touch.  I also had a low-grade fever during that entire period.  I had to see a doctor about the symptoms and I was diagnosed with myalgia.
Sometime after the shot I started having cold like symptoms that got progressively worse. And then I went and he put me on a steroid and said it was bronchitis. I had to call a second time and that doctor put me on a second round of the steroid  plus an antibiotic.
Shoulder pain; This case was reported by a consumer via call center representative and described the occurrence of shoulder pain in a 71-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   On 10th September 2019, the patient received Shingrix. On 10th September 2019, 1 hr after receiving Shingrix, the patient experienced shoulder pain. On an unknown date, the outcome of the shoulder pain was recovering/resolving.   It was unknown if the reporter considered the shoulder pain to be related to Shingrix.  Additional details were provided as follows: The case was reported by patient's wife. The reporter stated that the patient experienced shoulder pain. On the day of reporting the reporter called for treatment recommendations but was referred to a Healthcare provider. The reporter noted that the pain had gotten worse over the night. This case is 1 of the 2 linked cases, reported by the same reporter.
Immediately after injection of varicella, MMR, HEPA, and PREVNAR, patient started getting red patches of hive all over his face and neck.
7 days following vaccine administration, noticed itchiness at vaccine site on arm. Following day, the area was red and swollen, with increased itchiness.  No noticeable pain.
severe diarrhea for 5 follow days and counting; severe lost of liquid in each shot
Information has been received from a physician through a manufacturer pregnancy registry concerning a 32 year old female with a history of 5 pregnancies and 4 live births (one fetal loss at 16-20 weeks) who on 13-FEB-2007 was vaccinated with the first dose of Gardasil (lot #655619/1427F). Concomitant medication was not reported. On 13-NOV-2006, an ultrasound was performed results reported were fetal leiometry which corresponds the size and dates. On 04-DEC-2006, serum alpha-fetoprotein test was performed results were negative. On 13-FEB-2007, after the patient was vaccinated with Gardasil, the physician found out that the patient was pregnant. The physician reported that the pregnancy was normal to date. Follow-up information has been received from a physician. On 13-JAN-2007, an ultrasound performed showed adequate fetal growth since last sonography and fetal anatomy appears to be normal. On 13-APR-2007, an ultrasound performed showed biophysical profile 8/8, AFI 20.5 cm, S/D ratio 2.71, cervical length 4.44cm. On 23-APR-2007, an ultrasound performed showed adequate fetal growth since last ultrasound AFI 12.1 cm. On 24-APR-2007, the patient was diagnosed with intrauterine fetal demise and a female infant was delivered on 26-APR-2007 at 06:40, 3.235 kg. The placenta and cord were sent to pathology with no pathological diagnosis. Autopsy was refused. Clinically fetal death was due to cord accident, long umbilical cord, around body once and legs twice. Upon internal review, intrauterine fetal demise and umbilical cord complication were considered to be other important medical events. Additional ifnormation is not expected.
A few days after getting vaccine, had pain in L arm between shoulder and elbor with arm movement. Not strength deficits, no radiation pain, no numbness. Able to do all activity but has pain with active movement.
Ddizziness, light headedness, then passed out.  Administering nurse said that my eyes rolled back into my head and I started involuntary convulsions for a "few seconds".  I came to and did not have any recollection of the convulsions and/or seizures, but did recall passing out and waking up.
7 days after vaccine I woke with leg weakness. 3 days later my arms are weak; 7 days after vaccine I woke with leg weakness. 3 days later my arms are weak; It is hard to walk or hold; This is a spontaneous report from a contactable consumer (patient). A 41-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot Number: ER2613) via an unspecified route of administration in left arm on 21Mar2021 18:30 as single dose for covid-19 immunization. The patient was not pregnant at the time of vaccination. The patient's medical history included covid-19 prior to vaccination and concomitant medications were not reported. Did the patient receive any other vaccines within 4 weeks prior to the COVID vaccine: No. Patient had 7 days after vaccine I woke with leg weakness on 27Mar2021 08:00. 3 days later my arms are weak on. It is hard to walk or hold anything. No treatment was received for the events. The outcome of the events was not recovered.  No follow-up attempts are needed. No further information is expected.
In response to the vaccine on 21Dec2020 I started to get a headache; This is a spontaneous report from a contactable nurse (patient). An 50-year-old female patient received the first dose of BNT162B2 (Pfizer-BIONTECH Covid-19 Vaccine; Lot number: EH9899), via an unspecified route of administration in the left arm on 21Dec2020 at 12:00 PM in a hospital at a single dose for COVID-19 immunization. The patient's medical history was not reported. The patient was not pregnant at the time of vaccination, had no known drug allergies (NKDA), and did not receive any other vaccine within 4 weeks prior to the COVID vaccine. The patient was not diagnosed with COVID-19 prior to the vaccination and was not tested for COVID-19 post vaccination. Concomitant medication included diazepam (VALIUM). In response to the vaccine on 21Dec2020, the patient started to get a headache, 600 mg ibuprofen was taken. Overnight, she woke up with a debilitating headache, stayed in bed on 22Dec2020 taking Tylenol 1000 mg q (every) 8 hours and Ibuprofen 600 mg q (every) 6 hours to keep the headache manageable. The entire week, she had 2 days where if she didn't keep rotating the doses of Tylenol and Ibuprofen, the headache would become severe. The side effects included "headache" but this was no common headache and she was not a person who routinely gets them. It has been a week since the injection and she still had to continue the cycling of Tylenol/ibuprofen to maintain this headache, to continue ADL's. Outcome of the event was not recovered. The case was reported as non-serious (did not result in death, was not life-threatening, did not cause/prolong hospitalization, was not disabling/incapacitating, and did not result to any congenital anomaly/birth defect).
cough; Shortness of breath; This is a spontaneous report from a contactable consumer (patient). A 54-year-old non-pregnant female patient received unknown dose of bnt161b2 (Pfizer covid-19 vaccine, Solution for injection, Lot number: Unknown), via an unspecified route in the left arm on 11Feb2021 at 11:15 (age at vaccination: 54-year-old), as a single dose for covid-19 immunization. Medical history included covid scare: racing heart rate, aches, fatigue, shortness of breath and known allergies with amoxycillin and cashews. Concomitant medications included ergocalciferol (VITAMIN D), progesterone, cannabidiol (CBD) oil and melatonin. It was unknown if patient had covid prior to the vaccination. Since the vaccination, patient has not been tested for COVID-19. On 11Feb2021, patient experienced shortness of breath and racing heart rate after 2 covid scares. After vaccine: productive cough and much clearer lungs, no backache that made her think kidneys were involved. Patient stated that maybe vaccine fought against what was already in her body? Great!!! Patient did not receive any treatment for the events. The clinical outcome of the events was not recovered.  Follow-up attempts completed. No further information expected.
Shortly after the injection my left eye started to twitch. Monday (48 hrs) following the shot I had an intense stomach and left calve pain. The twitching got worse; several times an hour all day long. The stomach pain didn't last long (couple of hours) and the calve pain is mostly gone, but still happens on occasion. The twitching eye was the worse the three weeks following the injection. I still have the eye twitch several times a day, but better than several times an hour. I asked my doctor about it in email, but all she said was to report it and that being tired can cause that. This is not from being tired. It happens all different times / occasions. It's super disturbing. I'm thinking of requesting an appointment, since it's been nearly 6 weeks.
This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a male patient of unknown age. No information was provided regarding concomitant medications, concurrent conditions or medical history. On or about 18-Mar-2013, the patient was inoculated with ZOSTAVAX by a pharmacist as recommended for routine adult health maintenance for the prevention of shingles (dose, route, and lot # not provided). The vaccine did not prevent shingles as intended and the patient subsequently contracted a persistent strain condition of herpes zoster. On or about 17-Aug-2015, the patient was treated at a medical facility for a vesicular outbreak which was diagnosed as herpes zoster or shingles. As a direct and proximate result of the ZOSTAVAX vaccine, and/or despite receiving ZOSTAVAX for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment.  As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. The outcome of the events was unknown. Causality assessment was related. Additional information has been requested.
Developed painful urination around noon and then resolved after an increase in fluids. Then toward the evening noticed that arm started to feel tight and noticed swelling to injection site along with warm and redness to injection site.
Subsequent to receiving one dose of varicella virus vaccine live the pt experienced a fever of 101F. Three days later the pt experienced a breakthrough rash on his chest, legs and back with a total of 10 papules.
low grade temperatures; chills like 100 degrees; Weak; This is a spontaneous report from a COVAX US SUPPORT via a contactable reporter (Parent). A 38-years-old male patient received first dose of BNT162B2 (PFIZER-BIONTEC COVID-19 mRNA VACCINE, Solution for injection, lot number and expiry date were not reported), via an unspecified route of administration, in Arm, on an unspecified date in Apr2021, as a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient did not receive any vaccine within 4 weeks prior vaccinations. The patient took Pfizer covid vaccine because he wanted to be immunized to be inoculated. The reporter (patient's mother) calling on behalf of her son (patient) regarding the Pfizer covid vaccine. Her son recently got the second dose, and he was having adverse effects. She was calling to report. On an unspecified date in Apr201, the patient experienced low grade temperatures, chills like 100 degrees, and weak. She was not sure if its related directly to the vaccine, but she thought it's worth mentioning. Maybe to bring awareness to see if anyone else that had that batch, if anyone else had adverse effects. The first vaccine was in April. The second in May and he was fine with it and about two weeks ago out of the clear blue sky he was weak, dizzy, lightheaded, nauseous and vomiting. He was still weak, easily fatigued, just general malaise. It was medically significant, and it has improved a little. He was just taking supplements, vitamins, and trying to eat more properly. He was drinking a lot of fluids, electrolyte replacement, Pedialyte, and Gatorade. She has been to the Emergency Room with him three times, he's seen doctors and specialist and went to hematologist because of his liver. It went away she didn't have a date. Now it's not serious because it has subsided. He has lasting effects he is still weak. No dizziness noted. Whatever was going on has affected the integrity of his blood we have had blood work done and his liver enzymes were totally abnormal. All the symptoms were gone, vomiting was gone. The weakness fatigue and lost of appetite persists. The events required a visit to emergency room (3 times) and physician office. Outcome of the events was unknown.  Information on Batch/lot no. has been requested.
Muscle atrophy; Indention in arm muscle; Normal muscle soreness; Itchy feeling; This is a spontaneous report from a contactable consumer (patient):   A 58-year-old female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration, administered in the left arm, on 19Aug2021 at 14:00 (Lot Number: FC3187), at the age of 58 years old, as 2nd single dose for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient had received the 1st single dose of BNT162b2 on 29Jul2021 at 14:00 (lot number: FA6780) administered in the left arm. The patient had not received any other vaccines within 4 weeks prior to the BNT162b2 vaccination. Prior to vaccination, the patient had not been diagnosed with COVID-19 and since the vaccination, the patient had not been tested for COVID-19. The patient reported having normal muscle soreness and then 'approximately week' (as reported) itchy feeling. The onset date of the events was provided as 28Aug2021. At the time of the reporting the patient stated having a muscle atrophy and indention in arm muscle (as reported, onset date not specified). No treatment was required for the reported events. The outcome of the muscle soreness and itchiness was not specified, while the patient had not recovered from the muscle atrophy and indention in arm muscle at the time of the reporting. According to the reporter (patient), the reported events were non-serious.   Follow-up attempts are completed. No further information is expected.
Experienced the following for about 30 hours: chills, low fever, fatigue, generalized aches.  Some shortness of breath lasted for 8 days so far (not yet fully recovered).
65-year-old male with ESRD on HD along with ischemic cardiomyopathy and type 2 diabetes presents with new wounds on his feet.  These do not appear infected to me and are healing well.  However I will have him see physical therapy wound care for ongoing management to ensure they continue to heal well.  I do not have a good explanation for the underlying etiology but it is potentially vaccine related and I will make sure that this is reported to the database.  The patient will be on the look out for systemic signs of infection or increasing redness, pain, or discharge.  Since they have no pain, discharge, fevers, and that he has normal pulses with no increased warmth, I believe these do not represent nonhealing diabetic foot wounds or cellulitis/osteomyelitis
This is a spontaneous report received from a contactable reporter(s) (Other HCP). The reporter is the patient. A 22 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 19Dec2020 09:30 (Lot number: EK9231) at the age of 22 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Mild Hypothyroidism" (unspecified if ongoing). Concomitant medication(s) included: ADVIL [IBUPROFEN]. The following information was reported: VACCINATION SITE PAIN (non-serious), outcome "recovered", described as "sore arm (injection site pain)". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of vaccination site pain. Additional information: It was reported that the patient has no known allergies. The patient did not receive any other vaccine within 4 weeks prior to COVID-19 vaccine. Prior to vaccination, the patient was not been diagnosed with COVID-19 and post vaccination, the patient has been tested for COVID-19. The facility where the most recent COVID-19 vaccine was administered in hospital. No follow-up attempts are possible. No further information is expected.
This spontaneous report was received from a medical assistant and refers to a multiple unspecified patients of unknown age and gender. The patients' pertinent medical histories, concomitant medications and drug reactions or allergies were not reported. On an unknown dates, the patients were vaccinated with improperly stored doses of PNEUMOVAX 23 injection (lot # M043987 with expiration date at 30-JUN-2018, also reported as 20-OCT-2018; lot # N003997 with expiration date at 20-OCT-2018, lot # reported as M03997 with expiration date at 20-OCT-2018, lot # reported as M033338 with expiration date at 15-APR-2018; dose, route of administration and anatomical location were not reported), for prophylaxis. The administered doses of vaccine experienced multiple temperature excursions. From16-MAR-2017 to 31-MAR-2017, the doses of PNEUMOVAX 23 with lot numbers: M043987, M03997and M033338 were exposed to a temperature in the range between 47 degrees Fahrenheit (F) to 77 degrees Fahrenheit (F) for 1 hour and 52 minutes in total. On 21-MAR-2017, took place the longest (35 min) excursion with temperature of 49 degrees Fahrenheit (F). No details were reported regarding the temperature excursion with the doses of PNEUMOVAX 23 with lot # N003997. Data logger was used to track the temperature. No adverse effects were reported. No product quality complaint (PQC) was involved. This is one of several reports received from the same reporter. Additional information is not expected since all scheduled correspondence was received.; Sender's Comments: US-009507513-1705USA015600: US-009507513-1705USA015601: US-009507513-1705USA015602: US-009507513-1705USA015598: US-009507513-1705USA015597: US-009507513-1705USA015599:
pain at injection site; This is a spontaneous report from a non-contactable consumer via Pfizer sales representative. A 49-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number and Expiration date was not reported), via an unspecified route of administration, administered in Arm Left on 17Feb2021 (age at vaccination 49 years) as dose number unknown, single for covid-19 immunisation. Patient medical history and concomitant medications were not reported. The patient had no allergies. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient experienced pain at injection site on 18Feb2021. The patient did not receive any treatment for reported events. The outcome of events was recovering.  No follow-up attempts are possible; Information about lot/batch number cannot be obtained.